Healthtech/Analysis/ The 10 biggest healthtech stories of 2020 From covid response and psychedelic drugs to telemedicine and neurotech startups — here is a selection of Sifted healthtech stories of 2020. By Mimi Billing 28 December 2020 Sifted selects 10 healthtech stories from 2020 that has made a dent. Sifted selects 10 healthtech stories from 2020 that has made a dent. \Healthtech After 8 years of losses, digital health scaleup Kry is heading for profitability in 2023 By Mimi Billing 22 February 2023 Healthtech/Analysis/ The 10 biggest healthtech stories of 2020 From covid response and psychedelic drugs to telemedicine and neurotech startups — here is a selection of Sifted healthtech stories of 2020. By Mimi Billing 28 December 2020 This year the big story was coronavirus. We could have written pretty much every one of our articles about how startups in different sectors were dealing with the challenges and opportunities of the pandemic. In healthtech, startups pulled together to offer free tools to ease the strain on public healthcare and testing; others, like BioNTech, actually discovered vaccines. Some, like those in telemedicine and diagnostics, have seen a big jump in user numbers as health was forced to go digital. But not everything has been about Covid. There have been neurotech startups finding ways to treat diseases in entirely new ways (Elon Musk’s Neuralink isn’t the only show in town), companies that are using psychedelic drugs to treat mental health and European countries that are leading the way in revolutionising their healthcare systems. Here are 10 healthtech articles from Sifted that we think are worth revisiting: 1. Brunch with Sifted: psychedelic investor Christian Angermayer Instrumental in the founding of Compass Pathways and chairman of Atai Life Sciences, Christian Angermayer has been leading a global psychedelic renaissance. Christian Angermayer and Michael Stothard 2. The European answer to Elon Musk’s Neuralink From a chip in your brain to a headset on your head — here are the European startups that are breaking the boundaries in neurotechnology. 3. The Uber disease of telemedicine — why it may not be a great investment Some investors question the business models of the darlings of venture capital. 4. Inside Alan: the French healthtech startup with no meetings and transparent salaries Call it madness or genius — Alan’s distinctive company culture is one that few employees want to leave. Team Alan 5, The guinea pigs of Germany’s new healthcare revolution The German healthtech revolution that lets 20 something startups be the first to tap into 73m Germans’ health insurance. 6. In numbers: Europe’s healthtech industry in 2020 Europe’s healthtech industry is growing fast — here are the numbers you need to know. 7. Sextech startups boom in coronavirus pandemic Europe’s $30bn ‘sextech’ industry — made up of sex toys, apps and services — is being boosted by those with idle hands and minds. Unbound’s egg-shaped vibrator. 8. Inside Estonia’s pioneering digital health service Estonia’s digital healthcare service has managed what most other European health systems only dream of. Post-pandemic, what tips can others pick up? 9. List: Europe’s top femtech startups 2020 From CBD to saliva — these are the 22 femtech startups to know in Europe. 10. BioNTech: the German biotech startup behind the coronavirus vaccine Founded by migrants to Germany and funded by US and Asian investors: BioNTech is a classic European startup story. Related Articles ‘Slack for doctors’ app Siilo raises $10.5m By Amy Lewin Click here to read more How much do healthtech execs get paid? By Kai Nicol-Schwarz Click here to read more Some healthtech is failing — and that’s a major sign of progress By Lydia Yarlott Click here to read more Online food startups sizzling — but for how long? By Amy Lewin Click here to read more Most Read 1 \Healthtech Is Daniel Ek’s new body scanner worth the hype? Sifted tried it out 2 \Venture Capital VC diversity needs to change — and white men need to take responsibility 3 \Venture Capital New €3.75bn European Investment Fund pot to back late-stage VCs 4 \Sustainability Counteract closes £15m fund for carbon removal solutions 5 \Mobility Was the $5bn that VCs plugged into escooters worth it?